Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 8 Decent Work and Economic Growth -
SDG 16 Peace, Justice and Strong Institutions
Fingerprint
Dive into the research topics where Stefan Leucht is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Comparative efficacy and safety of clozapine and olanzapine in schizophrenia and related disorders: An updated systematic review
Asenjo-Lobos, C., Arancibia, M., Cortés-Jofré, M., Huang, T., Li, T., Madrid, E. & Leucht, S., Apr 2026, In: Psychiatry Research. 358, 116956.Research output: Contribution to journal › Review article › peer-review
-
Comparative efficacy and tolerability of antidopaminergic and muscarinic antipsychotics for acute schizophrenia: a network meta-analysis of randomised controlled trials indexed in international English and Chinese databases
Schneider-Thoma, J., Zhu, Y., Qin, M., Dong, Y., Guan, S., Wang, J., Tian, J., Lin, X., Rodolico, A., Siafis, S., Bighelli, I., Wehner, M., Veith, C., Krayer, F., Scheuring, E., Davis, J. M., Priller, J., Nikolakopoulou, A., Salanti, G. & Li, C. & 1 others, , 28 Feb 2026, In: The Lancet. 407, 10531, p. 876-891 16 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Die neue S3-Leitlinie Schizophrenie (living) 2025
Translated title of the contribution :The new S3 guideline on schizophrenia (living) 2025 Research output: Contribution to journal › Article › peer-review
Open Access -
Enhancing mental health care: a problem, resources and goals oriented multidimensional framework (PRoGO)
Leucht, S., König, B., di Francesco, A., Rodolico, A., Priller, J., Böge, K., Strube, W., Gensichen, J., Bechmann, P., ElDeeb, A., Hasan, A., Moritz, S., Jäger, M., Leucht, C., van Os, J. & Davis, J. M., Feb 2026, In: European Archives of Psychiatry and Clinical Neuroscience. 276, 1, p. 51-61 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Impact of Long-Acting Injectable Versus Oral Antipsychotic Treatment on All-Cause Discontinuation Risk in People with Early Phase Schizophrenia and Comorbid Substance Use Disorder: A Secondary Analysis of the EULAST Randomized Trial
EULAST Study Group, Jan 2026, In: CNS Drugs. 40, 1, p. 99-109 11 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations